Intercalated chemotherapy and erlotinib for advanced NSCLC:...

Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations

Zwitter, Matjaz, Stanic, Karmen, Rajer, Mirjana, Kern, Izidor, Vrankar, Martina, Edelbaher, Natalija, Kovac, Viljem
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
48
Language:
english
Journal:
Radiology and Oncology
DOI:
10.2478/raon-2014-0038
Date:
January, 2014
File:
PDF, 646 KB
english, 2014
Conversion to is in progress
Conversion to is failed